2-(1H-咪唑-5-基)-N-甲基乙胺二盐酸盐 | 16503-22-3

• 分子结构分类: 有机化合物 - 有机氮化合物
• 中文名称: 2-(1H-咪唑-5-基)-N-甲基乙胺二盐酸盐
• 英文名称: Nalpha-Methylhistamine dihydrochloride
• 英文别名: 2-(1H-imidazol-5-yl)-N-methylethanamine;dihydrochloride
• CAS: 16503-22-3
• 化学式: C6H13Cl2N3
• 分子量: 198.09
• InChiKey: AYUQICXJAMPXPF-UHFFFAOYSA-N

物化性质

• 熔点：
  173-176°C
• 溶解度：
  H2O：>20mg/mL

计算性质

• 辛醇/水分配系数(LogP)：
  1.02
• 重原子数：
  11
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  40.7
• 氢给体数：
  4
• 氢受体数：
  2

文献信息

• [EN] PYRROLO [2, 3 - B] PYRAZINE - 7 - CARBOXAMIDE DERIVATIVES AND THEIR USE AS JAK AND SYK INHIBITORS<br/>[FR] DÉRIVÉS DE PYRROLO[2,3-B]PYRAZINE-7-CARBOXAMIDE ET LEUR UTILISATION COMME INHIBITEURS DE JAK ET SYK
  申请人：HOFFMANN LA ROCHE

  公开号：WO2011144585A1

  公开（公告）日：2011-11-24

  The present invention relates to the use of novel pyrrolopyrazine derivatives of Formula (I), wherein the variables Q and R, R2, and R3 are defined as described herein, which inhibit JAK and SYK and are useful for the treatment of auto-immune and inflammatory diseases.

  本发明涉及使用式（I）的新型吡咯吡嗪衍生物，其中变量Q和R，R2和R3如本文所述定义，其抑制JAK和SYK并且适用于治疗自身免疫和炎症性疾病。
• Novel multicyclic compounds and the use thereof
  申请人：——

  公开号：US20020028815A1

  公开（公告）日：2002-03-07

  The present invention is directed to novel multicyclic molecules that mediate enzymatic activity. In particular, the compounds may be effective in the treatment of diseases or disease states related to the activity of PARP, VEGFR2, and MLK3 enzymes, including, for example, neurodegenerative diseases, inflammation, ischemia, and cancer.

  本发明涉及介导酶活性的新型多环分子。具体而言，这些化合物可能在治疗与PARP、VEGFR2和MLK3酶活性相关的疾病或疾病状态方面具有有效性，例如神经退行性疾病、炎症、缺血和癌症。
• POLY(ORGANOPHOSPHAZENE) COMPOSITION FOR BIOMATERIALS
  申请人：SONG Soo-Chang

  公开号：US20130004455A1

  公开（公告）日：2013-01-03

  Provided are a use of chemically-crosslinkable, poly(organophosphazene)s for biomaterials, chemically-crosslinkable poly(organophosphazene)s with a physiologically active substance covalently-bonded thereto, a use thereof for biomaterials, and a process for preparing the same. The chemical crosslinkings can be made by UV irradiation, and/or a crosslinker, and/or an additive, and/or an enzyme, and/or a mixing of at least one polymer.

  提供了一种用于生物材料的化学交联可用的聚（有机磷氮烷）的用途，与生理活性物质共价结合的化学交联聚（有机磷氮烷），以及其用于生物材料的用途，以及制备这些材料的过程。这种化学交联可以通过紫外辐射、交联剂、添加剂、酶、至少一种聚合物的混合等方法实现。
• NOVEL MULTICYCLIC COMPOUNDS AND THE USE THEREOF
  申请人：Chatterjee Sankar

  公开号：US20110059959A1

  公开（公告）日：2011-03-10

  The present invention is directed to novel multicyclic molecules that mediate enzymatic activity. In particular, the compounds may be effective in the treatment of diseases or disease states related to the activity of PARP, VEGFR2, and MLK3 enzymes, including, for example, neurodegenerative diseases, inflammation, ischemia, and cancer.

  本发明涉及新型多环分子，可介导酶活性。特别是，这些化合物可以在治疗与PARP、VEGFR2和MLK3酶活性相关的疾病或疾病状态方面发挥作用，包括例如神经退行性疾病、炎症、缺血和癌症。
• Multicyclic compounds and their use as inhibitors of PARP, VEGFR2 and MLK3 enzymes
  申请人：CEPHALON, INC.

  公开号：EP1754707A2

  公开（公告）日：2007-02-21

  The present invention is directed to novel multicyclic molecules of formula Ia that mediate enzymatic activity. In particular, the compounds may be effective in the treatment of diseases or disease states related to the activity of PARP, VEGFR2, and MLK3 enzymes, including, for example, neurodegenerative diseases, inflammation, ischemia, and cancer.

  本发明涉及介导酶活性的式 Ia 的新型多环分子。特别是，这些化合物可有效治疗与 PARP、VEGFR2 和 MLK3 酶活性有关的疾病或疾病状态，例如包括神经退行性疾病、炎症、缺血和癌症。